Evidence Based management of COVID 19
Sept. 6, 2021
New Zealand is lucky in many regards that when finally, we do start living with COVID rather than working to eliminate it, we can do so with the knowledge and learnings from our peers around the world. Currently, all mild COVID cases are whizzed off to Jett Park or other MIQ facilities, and so are not dealt with in primary care. There must come a time when that no longer happens.
Our doctors have recently been involved in educational sessions with Prof Dee Mangin. Dee is a New Zealand GP who is currently Professor and Director of the Primary Care Research Group at the University of Otago, Christchurch. She is also the David Braley Nancy Gordon Chair in Family Medicine at McMaster University, Canada. We are lucky to be able to leverage off her experiences in Canada throughout the pandemic. Dee's Canadian team at McMaster pull together all the studies done worldwide on treating and managing COVID and present them in a useful format for doctors like us.
Dee's advice has given us much reassurance. We anticipate that when we start living with COVID, 90% of it will be managed by us in the community and that 10% will require hospitalisation. She has provided a framework for how to manage COVID in the community and we are primed and ready for when and if this happens.
Most of our team have been asked questions, by our patients, about treatment options for COVID, and Dee has advised that we stick to providing only evidence-based options. This week, Bryan Betty, the Medical Director for the RNZCGP has issued some advice on one drug that there is some misinformation circulating about. In copying this in full I hope that this will explain why we are not prepared to issue prescriptions for ivermectin off-license. Prof Mangin pointed out that in India many patients were given cocktails of drugs in desperation to manage COVID. The steroids they were given inadvertently led to increased levels of parasitic infections (common in India) which then responded to the ivermectin.
Royal New Zealand College of General Practitioners.
Medical Director update 3 September: Ivermectin and COVID-19